​

Praxis Precision Medicines (PRAX) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

PRAX Stock Forecast

Praxis Precision Medicines (PRAX) stock forecast, based on 11 Wall Street analysts, predicts a 12-month average price target of $92.00, with a high of $120.00 and a low of $73.00. This represents a 64.40% increase from the last price of $55.96.

$20 $40 $60 $80 $100 $120 High: $120 Avg: $92 Low: $73 Last Closed Price: $55.96

PRAX Stock Rating

Praxis Precision Medicines stock's rating consensus is Buy, based on 11 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 8 Buy (72.73%), 2 Hold (18.18%), 1 Sell (9.09%), and 0 Strong Sell (0.00%).

Buy
Total 11 0 1 2 8 Strong Sell Sell Hold Buy Strong Buy

PRAX Price Target Upside V Benchmarks

TypeNameUpside
StockPraxis Precision Medicines64.40%
SectorHealthcare Stocks 19.91%
IndustryBiotech Stocks 55.52%

Price Target Trends

1M3M12M
# Anlaysts-112
Avg Price Target-$97.00$80.76
Last Closing Price$55.96$55.96$55.96
Upside/Downside-73.34%44.32%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Jul, 2538-1-12
Jun, 2538-1-12
May, 2537-1-11
Apr, 2537-1-11
Mar, 2537-1-11
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Jun 02, 2025Jay OlsonOppenheimer$97.00$39.82143.60%73.34%
Mar 03, 2025Truist Financial$85.00$33.55153.35%51.89%
Mar 03, 2025Guggenheim$120.00$33.55257.68%114.44%
Mar 03, 2025Needham$85.00$33.55153.35%51.89%
Mar 03, 2025Robert W. Baird$73.00$33.55117.59%30.45%
Sep 04, 2024Douglas TsaoH.C. Wainwright$60.30$29.25106.15%7.76%
Sep 04, 2024Ami FadiaNeedham$75.90$29.25159.49%35.63%
Sep 03, 2024Francois BriseboisOppenheimer$71.85$27.83158.17%28.40%
Sep 03, 2024Joon LeeTruist Financial$75.38$27.08178.36%34.70%
Aug 14, 2024Ami FadiaNeedham$72.90$25.73183.33%30.27%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Mar 03, 2025Deutsche BankBuyBuyhold
Feb 28, 2025WedbushBuyUnderperformdowngrade
Feb 28, 2025H.C. WainwrightBuyBuyhold
Oct 14, 2024OppenheimerOutperformOutperformhold
Sep 24, 2024Cowen & Co.BuyBuyhold
Sep 04, 2024Piper SandlerUnderperformUnderperformhold
Sep 04, 2024NeedhamBuyBuyhold
Sep 04, 2024H.C. WainwrightBuyBuyhold
Sep 03, 2024OppenheimerOutperformOutperformhold
Sep 03, 2024Cowen & Co.BuyBuyhold

Financial Forecast

EPS Forecast

$-25 $-20 $-15 $-10 $-5 $0 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-18.69$-10.21----
Avg Forecast$-20.43$-10.20$-11.47$-11.46$-9.52$-2.37
High Forecast$-14.03$-10.07$-8.88$-6.61$-3.02$-1.09
Low Forecast$-24.96$-10.32$-13.94$-19.33$-17.04$-3.75
Surprise %-8.52%0.10%----

Revenue Forecast

$0 $90M $180M $270M $360M $450M Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$2.45M$8.55M----
Avg Forecast$1.90M$1.47M$967.30K$31.98M$101.46M$308.29M
High Forecast$2.14M$1.83M$1.40M$46.35M$147.04M$446.80M
Low Forecast$1.82M$1.09M$565.43K$18.70M$59.31M$180.21M
Surprise %28.79%483.42%----

Net Income Forecast

$-200M $-160M $-120M $-80M $-40M $0 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-123.28M$-182.82M----
Avg Forecast$-123.28M$-67.22M$-75.24M$-85.53M$-66.14M$-15.63M
High Forecast$-92.52M$-66.40M$-58.53M$-43.59M$-19.92M$-7.19M
Low Forecast$-164.62M$-68.04M$-91.95M$-127.47M$-112.35M$-24.76M
Surprise %-171.96%----

PRAX Forecast FAQ

Is Praxis Precision Medicines stock a buy?

Praxis Precision Medicines stock has a consensus rating of Buy, based on 11 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 8 Buy, 2 Hold, 1 Sell, and 0 Strong Sell, reflecting a consensus that Praxis Precision Medicines is a favorable investment for most analysts.

What is Praxis Precision Medicines's price target?

Praxis Precision Medicines's price target, set by 11 Wall Street analysts, averages $92 over the next 12 months. The price target range spans from $73 at the low end to $120 at the high end, suggesting a potential 64.40% change from the previous closing price of $55.96.

How does Praxis Precision Medicines stock forecast compare to its benchmarks?

Praxis Precision Medicines's stock forecast shows a 64.40% upside, outperforming the average forecast for the healthcare stocks sector (19.91%) and outperforming the biotech stocks industry (55.52%).

What is the breakdown of analyst ratings for Praxis Precision Medicines over the past three months?

  • July 2025: 25.00% Strong Buy, 66.67% Buy, 0% Hold, 8.33% Sell, 0% Strong Sell.
  • June 2025: 25.00% Strong Buy, 66.67% Buy, 0% Hold, 8.33% Sell, 0% Strong Sell.
  • May 2025: 27.27% Strong Buy, 63.64% Buy, 0% Hold, 9.09% Sell, 0% Strong Sell.

What is Praxis Precision Medicines’s EPS forecast?

Praxis Precision Medicines's average annual EPS forecast for its fiscal year ending in December 2025 is $-11.47, marking a 12.34% increase from the reported $-10.21 in 2024. Estimates for the following years are $-11.46 in 2026, $-9.52 in 2027, and $-2.37 in 2028.

What is Praxis Precision Medicines’s revenue forecast?

Praxis Precision Medicines's average annual revenue forecast for its fiscal year ending in December 2025 is $967.3K, reflecting a -88.69% decrease from the reported $8.55M in 2024. The forecast for 2026 is $31.98M, followed by $101.46M for 2027, and $308.29M for 2028.

What is Praxis Precision Medicines’s net income forecast?

Praxis Precision Medicines's net income forecast for the fiscal year ending in December 2025 stands at $-75.239M, representing a -58.84% decrease from the reported $-183M in 2024. Projections indicate $-85.528M in 2026, $-66.138M in 2027, and $-15.629M in 2028.